Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV
Public ClinicalTrials.gov record NCT00035932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Open Label Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn how well atazanavir (ATV) works in combination with ritonavir (RTV) or saquinavir (SQV) with tenofovir (TDF) and a nucleoside to reduce the viral load of treatment experienced subjects with human immunodeficiency virus (HIV). There is a comparison arm with lopinavir (LPV)/RTV and TDF and a nucleoside.
Study identification
- NCT ID
- NCT00035932
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 571 participants
Conditions and interventions
Conditions
Interventions
- Atazanavir + ritonavir + tenofovir + nucleoside Drug
- Atazanavir + saquinavir + tenofovir + nucleoside Drug
- Lopinavir/ritonavir + tenofovir + nucleoside Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2001
- Primary completion
- Jun 30, 2003
- Completion
- Feb 28, 2009
- Last update posted
- Dec 23, 2010
2001 – 2009
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | San Francisco | California | 94121 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Boulder | Colorado | 80304 | — |
| Not listed | Altamonte Springs | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | 33306 | — |
| Not listed | Fort Lauderdale | Florida | 33308 | — |
| Not listed | Miami Beach | Florida | 33160 | — |
| Not listed | Orlando | Florida | 32801 | — |
| Not listed | Decatur | Georgia | — | — |
| Not listed | Honolulu | Hawaii | 96816 | — |
| Not listed | Boise | Indiana | — | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | New Orleans | Louisiana | — | — |
| Not listed | Brookline | Massachusetts | — | — |
| Not listed | Fall River | Massachusetts | 02720 | — |
| Not listed | East Orange | New Jersey | — | — |
| Not listed | Newark | New Jersey | 07103 | — |
| Not listed | Buffalo | New York | 14215 | — |
| Not listed | Manhasset | New York | 11030 | — |
| Not listed | New York | New York | 10019 | — |
| Not listed | Rochester | New York | 14620 | — |
| Not listed | Huntersville | North Carolina | 28078 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Winston-Salem | North Carolina | 29203 | — |
| Not listed | Akron | Ohio | — | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | 77006 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00035932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2010 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00035932 live on ClinicalTrials.gov.